首页> 外国专利> (Plasmodium falciparum) ribonucleotide reductase, encoding DNA, and inhibitors

(Plasmodium falciparum) ribonucleotide reductase, encoding DNA, and inhibitors

机译:(恶性疟原虫)核糖核苷酸还原酶,编码DNA和抑制剂

摘要

This invention relates to the ribonucleotide reductase of Plasmodium falciparum (Pf RR), to the subunits of Pf RR (Pf R1 and Pf R2), and to compounds comprising peptides derived from the Pf R2 C-terminus sequence that inhibit the action of protozoal RR. The invention provides a method for the prevention and treatment of malaria caused by P. falciparum by controlling the proliferation of P. falciparum comprising administering to a patient at least one peptide according to the invention. Antimalarial compositions are provided which comprise a pharmaceutically acceptable carrier and at least one peptide according to the invention which inhibits the P. falciparum ribonucleotide reductase reduction of ribonucleotides to 2'-deoxyribonucleotides. Also provided are methods for diagnosing malaria and for screening potential antimalarial agents.
机译:本发明涉及恶性疟原虫(Pf RR)的核糖核苷酸还原酶,Pf RR的亚基(Pf R1和Pf R2),以及涉及包含衍生自Pf R2 C末端序列的肽的化合物,该肽抑制原生动物RR的作用。 。本发明提供了一种通过控制恶性疟原虫的增殖来预防和治疗由恶性疟原虫引起的疟疾的方法,该方法包括向患者施用至少一种根据本发明的肽。提供了抗疟组合物,其包含药学上可接受的载体和至少一种根据本发明的肽,其抑制恶性疟原虫核糖核苷酸还原酶还原为2'-脱氧核糖核苷酸。还提供了用于诊断疟疾和筛选潜在抗疟药的方法。

著录项

  • 公开/公告号AU685179B2

    专利类型

  • 公开/公告日1998-01-15

    原文格式PDF

  • 申请/专利权人 THE UNIVERSITY OF PENNSYLVANIA;

    申请/专利号AU19940079712

  • 申请日1994-10-07

  • 分类号C07H21/04;C07K14/445;C12N1/21;C12N15/63;C12N15/70;C12P21/00;C12P19/34;C12Q1/68;A61K38/03;A61K38/04;A61K38/07;A61K38/08;A61K38/10;A61K38/16;A61K39/015;

  • 国家 AU

  • 入库时间 2022-08-22 02:52:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号